Adverum Biotechnologies Stock (NASDAQ: ADVM) stock price, news, charts, stock research, profile.
Open | $9.450 |
Close | $9.300 |
Volume / Avg. | 340.268K / 270.807K |
Day Range | 9.190 - 10.760 |
52 Wk Range | 7.400 - 29.700 |
Market Cap | $193.038M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 5.49% |
Days to Cover | 5.08 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Adverum Biotechnologies (NASDAQ: ADVM) through any online brokerage.
Other companies in Adverum Biotechnologies’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Renovaro (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and bluebird bio (NASDAQ:BLUE).
The latest price target for Adverum Biotechnologies (NASDAQ: ADVM) was reported by HC Wainwright & Co. on Friday, May 10, 2024. The analyst firm set a price target for 30.00 expecting ADVM to rise to within 12 months (a possible 222.58% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Adverum Biotechnologies (NASDAQ: ADVM) is $9.3 last updated May 10, 2024 at 4:14 PM EDT.
There are no upcoming dividends for Adverum Biotechnologies.
Adverum Biotechnologies’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Adverum Biotechnologies.
Adverum Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.